SALT LAKE CITY - Lipocine Inc. (NASDAQ: NASDAQ:LPCN), a biopharmaceutical company with a market capitalization of approximately $24 million, announced today that it will conduct a phase 3 safety and ...
Memsi, which contains 'cathinone' as one of its main ingredients - shares this ingredient with Captagon, utilized by Hamas ...